1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : BIOTECH
  4. SYNDAX PHARMACEUTICALS INC
Syndax Pharmaceuticals Inc XNAS: SNDX

Syndax Pharmaceuticals Inc Live Share Price Today, Share Analysis and Chart

Weak Stock
about

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a ...

Read More
9.23 0.02 (0.22%)
63.18% Fall from 52W High
451.6K
XNAS Volume

XNAS 16 Jul, 2025 12:58 PM (EDT)

Watchlist

Portfolio

Alert

Share
Durability score
Low Financial Strength
11.1 / 100
Valuation Score
Expensive Valuation
10.3 / 100
Momentum Score
Technically Bearish
32.0 / 100
Weak Stock These stocks are the ones with poor quality, financials and technicals. This indicates that investors should be highly watchful with these stocks. View Similar Embed DVM
Analyst Price Target
33
1Yr Price target upside is 254%
12 analysts

3

S

19

W

4

O

0

T

SWOT Analysis

Syndax Pharmaceuticals Inc Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..